Testing the Use of BRAF-Targeted Therapy After Surgery and Usual Chemotherapy for BRAF-Mutated Colon Cancer

Clinical trial NCT05710406 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05710406
Sponsor: Alliance for Clinical Trials in Oncology
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Colon Adenocarcinoma Microsatellite Stable Colon Carcinoma Stage IIB Colon Cancer AJCC v8 Stage IIC Colon Cancer AJCC v8 Stage III Colon Cancer AJCC v8

Start date: 2023-08-16
Primary completion: 2034-06-01
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.